ArticleJTO clinical and research reports2026
Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.
Kiyohide Komuta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.